Financhill
Back

Heron Therapeutics Stock Predictions

Heron Therapeutics Stock Forecast

  • Is Heron Therapeutics Stock Undervalued?
    The current Heron Therapeutics [HRTX] share price is $3.05. The Score for HRTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • HRTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Heron Therapeutics Stock Go Up Next Year?

Data Unavailable

Heron Therapeutics Stock Rating

Data Unavailable

Heron Therapeutics Stock Price History

Is HRTX stock going to rise?

  • The current trend is relatively stagnant and HRTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
herontx.com

52-Week Data

52-Week High:
3.93
52-Week Low:
0.50

Prediction Charts

Market Cap:
458.74M
Price in USD:
3.05
Volume:
1.19M
Beta:
1.34

Technical Analysis

SMA50:
3.12
SMA100:
2.90
SMA200:
2.12
52-Wk Change:
151.65%

Stock Predictions

  • Is Heron Therapeutics stock public?
    Yes, Heron Therapeutics is a publicly traded company.
  • What is the Heron Therapeutics stock quote today?
    The Heron Therapeutics stock price is 3.05 USD today.
  • How to buy Heron Therapeutics stock online?
    You can buy Heron Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-5 3.61 3.82 3.84 3.57
Jun-6 3.81 3.63 3.86 3.61
Jun-7 3.70 3.60 3.74 3.53
Jun-10 3.60 3.70 3.72 3.56
Jun-11 3.67 3.64 3.72 3.45
Jun-12 3.78 3.66 3.93 3.60
Jun-13 3.68 3.64 3.75 3.58
Jun-14 3.58 3.60 3.71 3.56
Jun-17 3.60 3.23 3.61 3.21
Jun-18 3.22 3.42 3.52 3.22
Jun-20 3.39 3.29 3.48 3.27
Jun-21 3.31 3.24 3.43 3.18
Jun-24 3.23 3.17 3.31 3.13
Jun-25 3.20 3.05 3.25 3.03

Heron Therapeutics Earnings

Data Unavailable

Heron Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $0.13 per share.

* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.